According to a new press release, “EPAM Systems, Inc., a leading global provider of digital platform engineering and software development solutions, today announced that the EPAM Cloud Pipeline, an industry-leading life sciences solution designed to accelerate drug discovery clinical research, is now released in the Microsoft Azure Marketplace. An open source, web-based platform, the EPAM Cloud Pipeline enables scientists to build and run customized scripts and workflows required to support genomics analysis, modeling and simulation, as well as machine learning.”
The release goes on, “The EPAM Cloud Pipeline enables scientists to build and run customized scripts and workflows required to support genomics analysis, modeling and simulation, as well as machine learning. The solution is available as a direct integration between cloud and on-premise solutions. It wraps Azure computing and storage resources into a single service, providing an easy and scalable approach required to accomplish a wide range of scientific tasks. Additionally, the EPAM Cloud Pipeline can be integrated with Microsoft Genomics to provide on-demand performance, security and scalability to genomic computation.”
It adds, “An open source, web-based cloud platform, the EPAM Cloud Pipeline enables healthcare and life sciences organizations to accelerate drug discovery research. EPAM customers can now take advantage of the scalability, reliability and agility of Azure’s public cloud for streamlined deployment and cost-effective management.”
Read more at PR Newswire.
Image used under license from Shutterstock.com